A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel (Q37886280)

24 August 2017

1 reference

title

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel (English)

1 reference

24 August 2017

0 references

0 references

0 references

1 reference

1 reference

1 reference

1 reference

33

Stefan Zeuzem

1 reference

24 August 2017

Rui T Marinho

21

0 references

Homie Razavi

Homie A Razavi

2

0 references

Martin Lagging

Martin Lagging

16

0 references

Krzysztof Simon

Krzysztof Simon

27

0 references

Robert Flisiak

Robert Flisiak

9

0 references

Thierry Poynard

Thierry Poynard

23

0 references

Alfredo Alberti

Alfredo Alberti

3

0 references

Enos Bernasconi

4

Enos Bernasconi

1 reference

24 August 2017

14

Waldemar Halota

1 reference

24 August 2017

22

Stanislas Pol

1 reference

24 August 2017

20

Patrick Marcellin

1 reference

24 August 2017

5

Maria Buti

1 reference

24 August 2017

13

Ioannis Goulis

1 reference

24 August 2017

1

Markus Cornberg

1 reference

24 August 2017

7

Olav Dalgard

1 reference

24 August 2017

24

Massimo Puoti

1 reference

24 August 2017

Curtis Cooper

6

1 reference

24 August 2017

John F Dillion

8

1 reference

24 August 2017

Xavier Forns

10

1 reference

24 August 2017

Sona Frankova

11

1 reference

24 August 2017

Adrian Goldis

12

1 reference

24 August 2017

Bela Hunyady

15

1 reference

24 August 2017

Angela Largen

17

1 reference

24 August 2017

Michael Makara

18

1 reference

24 August 2017

Spilios Manolakopoulos

19

1 reference

24 August 2017

Olga Sagalova

25

1 reference

24 August 2017

Scott Sibbel

26

1 reference

24 August 2017

Carolyn Wallace

28

1 reference

24 August 2017

Kendra Young

29

1 reference

24 August 2017

Cihan Yurdaydin

30

1 reference

24 August 2017

Eli Zuckerman

31

1 reference

24 August 2017

Francesco Negro

32

1 reference

24 August 2017

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

31 Suppl 2

1 reference

24 August 2017

30-60

1 reference

Increased mortality among persons infected with hepatitis C virus

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The changing epidemiology of hepatitis C virus infection in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and estimated incidence of blood-borne viral pathogen infection in organ and tissue donors from northern Alberta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Rapid Genotyping of Hepatitis C Virus by Primer-Specific Extension Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus infection among injecting drug users in the Czech Republic -- prevalence and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Assessment and proposal of a new combination of screening criteria for hepatitis C in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

An incident case-control study of modes of hepatitis C virus transmission in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Screening for markers of infections transmitted by transfusions in the blood collected in France from 1996 to 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

[Screening for markers of blood-borne diseases in donated units collected in France from 1993 to 1995].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

[Descriptive epidemiology of hepatitis C virus infection in France in 1996].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

[Prevalence of HBV, HCV, HIV and HTLV in autologous blood donors in France between 1993 and 2000]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiology of HCV infection in the general population and in blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

A twelve year natural history of hepatitis C virus infection in hemodialyzed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus (HCV) genotype analysis in apparently healthy anti-HCV-positive Parisian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus genotypes in French blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus infection in children admitted to an urban hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Low prevalence of chronic hepatitis C, but high prevalence of elevated aminotransferases in a cohort of 2026 patients referred for orthopaedic surgery in the eastern part of Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Multiple viral hepatitis in injection drug users and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus infection in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Seroprevalence of hepatitis A, B and C markers in Greek warship personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus infection in a cohort of pregnant women in northern Greece and transmission of HCV from mother to child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The detection of hepatitis C virus in South Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C at the israeli national hemophilia center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis c virus infection in employees of a large university hospital in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Characteristics of HCV positive patients in an Italian urban psychiatric unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus infection in different population groups in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of HCV infection among health care workers in a hospital in central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

High prevalence of HCV infection among the general population in a rural area of central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Impact of hepatitis C virus infection on healthy subjects on an Italian island

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C infection in an Italian population not selected for risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus antibodies in a clinic-based group of Italians from one geographic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiology of hepatitis C virus infection in an area of Southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Low prevalence of anti-HCV antibody among Italian children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of anti-HCV in subjects of various age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Liver disease in anti-hepatitis C virus-positive Norwegian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

21 January 2018

HCV infection in Poland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiological aspects of hepatitis C in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis B and C seroprevalence in Novosibirsk, western Siberia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Molecular epidemiology of the hepatitis C virus in Western Siberia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

21 January 2018

[Hepatitis C in Spain].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

High Rate of Infection with Hepatitis C Virus Genotype 4 in a District of Galicia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Community-based seroepidemiological survey of HCV infection in Catalonia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Nosocomial transmission of HCV in the liver unit of a tertiary care center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus infection in the general population of northern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis C virus genotypes in a Spanish liver transplant unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Risk factors for hepatitis A, B and C virus infection among Swedish expatriates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Genotyping of hepatitis C virus by Taqman real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Low prevalence of hepatitis C virus antibody among Swiss dental health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Simulation of hepatitis C based on a mandatory reporting system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Transmission routes of chronic hepatitis C and their relation to HCV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The epidemiology of hepatitis C in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Intrauterine device use does not increase the incidence of anti-hepatitis C seropositivity among monogamous women in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis B virus and hepatitis C virus seroprevalence in the elderly living in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The distribution of hepatitis C virus genotypes in Turkish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C virus infection in the asymptomatic British blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Hepatitis C viraemia in United Kingdom blood donors. A multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The prevalence of hepatitis C in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

A study of hepatitis C prevalence in healthcare workers in the West of Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

HCV prevalence in pregnant women in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The epidemiology of hepatitis C in a UK health regional population of 5.12 million

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

The burden of hepatitis C in Sweden: a national study of inpatient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

Is the spread of HCV in Southern Italy attributable to iatrogenic transmission through unsterile injections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02539.X

10.1111/J.1478-3231.2011.02539.X

21 January 2018

Identifiers

DOI

1 reference

release_t5nwshnqvzbxti5f5wm3n5ff3e

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t5nwshnqvzbxti5f5wm3n5ff3e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference